Literature DB >> 30262575

Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model.

Valentina Mercurio1,2, Nermin Diab1,3, Grace Peloquin1, Traci Housten-Harris1, Rachel Damico1, Todd M Kolb1, Stephen C Mathai1, Paul M Hassoun1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30262575     DOI： 10.1183/13993003.00497-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  12 in total

Review 1.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

2.  Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.

Authors:  Yue Shi; Xingbei Dong; Xiaoyun Hu; Li Weng; Yongtai Liu; Jinzhi Lai; Zhuang Tian; Jiuliang Zhao; Mengtao Li; Jinmin Peng; Qian Wang; Xiaofeng Zeng
Journal:  BMC Pulm Med       Date:  2022-07-05       Impact factor: 3.320

Review 3.  Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.

Authors:  Shu-Hao Wu; Yih-Jer Wu
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

Review 4.  Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.

Authors:  Umberto Attanasio; Alessandra Cuomo; Flora Pirozzi; Stefania Loffredo; Pasquale Abete; Mario Petretta; Gianni Marone; Domenico Bonaduce; Amato De Paulis; Francesca Wanda Rossi; Carlo Gabriele Tocchetti; Valentina Mercurio
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

5.  Modulation of Redox Signaling in Chronic Diseases and Regenerative Medicine.

Authors:  Serena Zacchigna; Laura Sartiani; Claudia Penna; Gilda Varricchi; Carlo G Tocchetti
Journal:  Oxid Med Cell Longev       Date:  2019-04-23       Impact factor: 6.543

6.  Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey.

Authors:  Yalın Tolga Yaylalı; Ibrahim Başarıcı; Burçak Kılıçkıran Avcı; Murat Meriç; Ümit Yaşar Sinan; Hande Şenol; Mehmet Serdar Küçükoğlu; Zeki Öngen
Journal:  Anatol J Cardiol       Date:  2019-06       Impact factor: 1.596

Review 7.  The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.

Authors:  Michael H Lee; Todd M Bull
Journal:  F1000Res       Date:  2019-12-19

8.  Selexipag in the management of pulmonary arterial hypertension: an update.

Authors:  J Gerry Coghlan; Christina Picken; Lucie H Clapp
Journal:  Drug Healthc Patient Saf       Date:  2019-08-06

9.  Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Vasiliki Kalliopi Bournia; Iraklis Tsangaris; Loukianos Rallidis; Dimitrios Konstantonis; Frantzeska Frantzeskaki; Anastasia Anthi; Stylianos E Orfanos; Eftychia Demerouti; Panagiotis Karyofillis; Vassilis Voudris; Katerina Laskari; Stylianos Panopoulos; Panayiotis G Vlachoyiannopoulos; Petros P Sfikakis
Journal:  Diagnostics (Basel)       Date:  2020-01-19

10.  Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment.

Authors:  Clara Hjalmarsson; Barbro Kjellström; Kjell Jansson; Magnus Nisell; David Kylhammar; Mohammad Kavianipour; Göran Rådegran; Stefan Söderberg; Gerhard Wikström; Dirk M Wuttge; Roger Hesselstrand
Journal:  ERJ Open Res       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.